CFHR1 and IgA glomerulonephritis: They can also inhibit the binding of CFH and complement component 3b and compete with CFH for the binding site on complement component 3b.[26] A previous study confirmed that variations in multiple loci of CFHR1 and CFHR3 are related to the risk of IgA nephropathy (IgAN).